Please provide your email address to receive an email when new articles are posted on . Patients with genetic risk for different glaucoma subtypes had an associated risk for different visual field ...

Please provide your email address to receive an email when new articles are posted on . Disc hemorrhage location had significant links to the area of clustered visual field progression. Inferior and ...

A risk score incorporating genetic variants for open-angle glaucoma is accurate enough to help with diagnosis of the condition, an interim study reveals. Although hundreds of genetic changes are ...

Open-angle glaucoma often has no symptoms until vision loss begins, so regular screening is important. You can use eye drops ...

From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...

Primary open-angle glaucoma (POAG) is among the leading causes of irreversible blindness. Early detection and treatment are crucial for vision preservation, and research to identify genes associated ...

Nucleoside and nucleotide reverse transcriptase inhibitors use remained significantly associated with an increased risk for developing primary open-angle glaucoma after adjustment for family history.

Glaucoma is not fatal. Without treatment, glaucoma can cause significant vision loss and eventually blindness, but early treatment can help protect vision and slow the progression of the disease.

Smoking intensity was shown to be associated with larger microvasculature dropout areas in patients with glaucoma, particularly those with more severe disease. Smoking intensity is associated with ...

A licensing agreement between SERI and Eyexora Global has launched Y.ora Vision, a new ophthalmic medical device company.